Dr Reddy's Laboratories

Dr Reddy's Laboratories News

Dr Reddy’s Laboratories faces class action suit

“The lawsuit alleges the company made materially false and/or misleading statements or omissions in connection with its corporate quality system and specifically in connection with a warning letter from the US Food and Drug Administration dated November 6, 2015, and a letter from the Regierung von Oberbayern in Germany dated August 10, 2017.."

US court asks DRL to halt sale of ‘Purple Pills’

The order has been passed pending further hearing or trial.

Advertising

Dr Reddy’s, IPCA Labs products come under Canada govt scanner

IPCA also got Form 483 in August with six serious deviations for its Madhya Pradesh facility.

Dr Reddy's Lab, Ranbaxy, Glenmark shares hit by worries about Russia, Ukraine sales

Dr Reddys Laboratories has the highest exposure to Russia and former Soviet republics.

BSE Sensex jumps by 115 pts,Reliance Industries,Infosys shares gain

BSE Sensex gained 0.71 pct,while broader NSE Nifty index ended higher 0.81 pct.

PM Manmohan Singh pep-talk lifts Sensex by 219 pts to over two-week high,TCS shares hit all-time high

Today is the highest close for Sensex since August 14 (19,367.59).

Advertising

Dr Reddy’s net up 7% at Rs 361 cr

Dr Reddy’s Laboratories today said its net profit rose by over seven per cent to Rs 361 crore for the quarter ended June 30,primarily driven by North American revenues

Dr Reddys Laboratories sued for 'infringement' of thyroid injection patent

US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing.

Dr Reddy's Laboratories quarterly net profit up 67%,dividend at Rs 15

Company's major segments include global generics,pharmaceutical services and active ingredients.

LIC sells 2.13 per cent stake in Dr. Reddy's Laboratories

LIC shareholding in India's second largest drug maker Dr. Reddy's Laboratories fell to 4.1%.

Advertising